ADP	Adenosine diphosphate
AI	Artificial intelligence
aPTT	Activated partial thromboplastin time
ASCO	American Society of Clinical Oncology
BSH	British Society for Haematology
CAT	Cancer-associated thrombosis
CRNMB	Clinically relevant non-major bleeding
CrCl	Creatinine clearance
CRT	Catheter-related thrombosis
CVC	Central venous catheter
CYP3A4	Cytochrome P450 3A4
DNA	Deoxyribonucleic acid
DOAC	Direct oral anticoagulant
DVT	Deep vein thrombosis
ERAS	Enhanced Recovery After Surgery
ESMO	European Society for Medical Oncology
FIX	Coagulation factor IX
FXI	Coagulation factor XI
FXIa	Activated coagulation factor XI
FXII	Coagulation factor XII
FXIIa	Activated coagulation factor XII
GI	Gastrointestinal
GU	Genitourinary
HCC	Hepatocellular carcinoma
ICH	Intracranial hemorrhage
INR	International normalized ratio
LMWH	Low-molecular-weight heparin
NCCN	National Comprehensive Cancer Network
NETs	Neutrophil extracellular traps
PARP	Poly(ADP-ribose) polymerase
PE	Pulmonary embolism
P-gp	P-glycoprotein
PICC	Peripherally inserted central catheter
PRISMA	Preferred Reporting Items for Systematic Reviews and Meta-Analyses
RCT	Randomized controlled trial
RIETE	Registro Informatizado de la Enfermedad TromboEmbólica (Computerized Registry of Venous Thromboembolic Disease)
SEMI	Spanish Society of Internal Medicine
SEOM	Spanish Society of Medical Oncology
START	Strategies for Anticoagulation in Patients with Thrombocytopenia and Cancer-Associated Thrombosis
TESEO	Thrombosis and Neoplasia Registry of SEOM
TURBT	Transurethral resection of bladder tumor
UFH	Unfractionated heparin
VEGF	Vascular endothelial growth factor
VEGFR-TKI	Vascular endothelial growth factor receptor tyrosine kinase inhibitor
VKA	Vitamin K antagonist
VTE	Venous thromboembolism
VTE-BLEED	Bleeding-risk prediction score for patients with venous thromboembolism